Reduction of AZGP1 predicts poor prognosis in esophageal squamous cell carcinoma patients in Northern China

References

• KamangarFDoresGMAndersonWFPatterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the worldJ Clin Oncol200624142137215016682732
   PubMed Web of Science ®Google Scholar
• WheelerJBReedCEEpidemiology of esophageal cancerSurg Clin North America201292510771087
   PubMed Web of Science ®Google Scholar
• Shahbaz SarwarCMLuketichJDLandreneauRJAbbasGEsophageal cancer: an updateInt J Surg20108641742220601255
   PubMed Web of Science ®Google Scholar
• HongoMNagasakiYShojiTEpidemiology of esophageal cancer: orient to Occident. Effects of chronology, geography and ethnicityJ Gastroenterol Hepatol200924572973519646015
   PubMed Web of Science ®Google Scholar
• PortaleGHagenJAPetersJHModern 5-year survival of resectable esophageal adenocarcinoma: single institution experience with 263 patientsJ Am Coll Surg20062024588596 discussion 596–58816571425
   PubMed Web of Science ®Google Scholar
• LiXHWangXPGuWSClinical significance of preoperative thrombin time in patients with esophageal squamous cell carcinoma following surgical resectionPLoS One20151010e014032326469700
   PubMedGoogle Scholar
• ChaoYKChangCBChuangWYCorrelation between tumor regression grade and clinicopathological parameters in patients with squamous cell carcinoma of the esophagus who received neoadjuvant chemoradiotherapyMedicine (Baltimore)20159434e140726313788
   PubMedGoogle Scholar
• GuoJCHuangTCLinCCPostchemoradiotherapy pathologic stage classified by the American Joint Committee on the cancer staging system predicts prognosis of patients with locally advanced esophageal squamous cell carcinomaJ Thorac Oncol201510101481148926313683
   PubMedGoogle Scholar
• XieDShamJSZengWFHeterogeneous expression and association of beta-catenin, p16 and c-myc in multistage colorectal tumorigenesis and progression detected by tissue microarrayInt J Cancer2003107689690214601048
   PubMed Web of Science ®Google Scholar
• American Joint Committee on CancerAJCC Guidelines7th Edition2009 Available from: www.cancerstaging.org
   Google Scholar
• BrownRSWahlRLOverexpression of Glut-1 glucose transporter in human breast cancer. An immunohistochemical studyCancer19937210297929858221565
   PubMedGoogle Scholar
• HassanMIWaheedAYadavSSinghTPAhmadFZinc alpha 2-glycoprotein: a multidisciplinary proteinMol Cancer Res20086689290618567794
   PubMedGoogle Scholar
• IrmakSTilkiDHeukeshovenJStage-dependent increase of orosomucoid and zinc-alpha2-glycoprotein in urinary bladder cancerProteomics20055164296430416196100
   PubMedGoogle Scholar
• Abdul-RahmanPSLimBKHashimOHExpression of high-abundance proteins in sera of patients with endometrial and cervical cancers: analysis using 2-DE with silver staining and lectin detection methodsElectrophoresis200728121989199617503403
   PubMedGoogle Scholar
• LeiGAranyISelvanayagamPDetection and cloning of epidermal zinc-alpha 2-glycoprotein cDNA and expression in normal human skin and in tumorsJ Cell Biochem19976722162229328826
   PubMedGoogle Scholar
• BurgiWSchmidKPreparation and properties of Zn-alpha 2-glycoprotein of normal human plasmaJ Biol Chem19612361066107413689030
   PubMedGoogle Scholar
• BaoYBingCHunterLJenkinsJRWabitschMTrayhurnPZinc-alpha2-glycoprotein, a lipid mobilizing factor, is expressed and secreted by human (SGBS) adipocytesFEBS Lett20055791414715620688
   PubMedGoogle Scholar
• RussellSTZimmermanTPDominBATisdaleMJInduction of lipolysis in vitro and loss of body fat in vivo by zinc-alpha2-glycoproteinBiochim Biophys Acta200416361596814984739
   PubMedGoogle Scholar
• BingCBaoYJenkinsJZinc-alpha2-glycoprotein, a lipid mobilizing factor, is expressed in adipocytes and is up-regulated in mice with cancer cachexiaProc Natl Acad Sci U S A200410182500250514983038
   PubMed Web of Science ®Google Scholar
• BryskMMLeiGAdler-StorthzKZinc-alpha2-glycoprotein expression as a marker of differentiation in human oral tumorsCancer Lett1999137111712010376801
   PubMedGoogle Scholar
• KongBMichalskiCWHongXAZGP1 is a tumor suppressor in pancreatic cancer inducing mesenchymal-to-epithelial transdifferentiation by inhibiting TGF-beta-mediated ERK signalingOncogene201029375146515820581862
   PubMedGoogle Scholar
• Diez-ItzaISanchezLMAllendeMTVizosoFRuibalALopez-OtinCZn-alpha 2-glycoprotein levels in breast cancer cytosols and correlation with clinical, histological and biochemical parametersEur J Cancer199329A9125612608343263
   PubMedGoogle Scholar
• HaleLPPriceDTSanchezLMDemark-WahnefriedWMaddenJFZinc alpha-2-glycoprotein is expressed by malignant prostatic epithelium and may serve as a potential serum marker for prostate cancerClin Cancer Res20017484685311309332
   PubMedGoogle Scholar
• HuangCYZhaoJJLvLDecreased expression of AZGP1 is associated with poor prognosis in primary gastric cancerPLoS One201387e6915523935945
   PubMedGoogle Scholar
• HeNBryskHTyringSKOhkuboIBryskMMZinc-alpha(2)-glycoprotein hinders cell proliferation and reduces cdc2 expressionJ Cell Biochem Suppl2001Suppl 3616216911455581
   PubMedGoogle Scholar
• DescazeaudAde la TailleAAlloryYCharacterization of ZAG protein expression in prostate cancer using a semi-automated microscope systemProstate200666101037104316598739
   PubMed Web of Science ®Google Scholar
• LapointeJMalhotraSHigginsJPhCAP-D3 expression marks a prostate cancer subtype with favorable clinical behavior and androgen signaling signatureAm J Surg Pathol200832220520918223322
   PubMedGoogle Scholar
• HuangYLiLZZhangCZDecreased expression of zinc-alpha2-glycoprotein in hepatocellular carcinoma associates with poor prognosisJ Transl Med20121010622625427
   PubMedGoogle Scholar
• AgesenTHSveenAMerokMAColoGuideEx: a robust gene classifier specific for stage II colorectal cancer prognosisGut201261111560156722213796
   PubMed Web of Science ®Google Scholar
• JiDLiMZhanTPrognostic role of serum AZGP1, PEDF and PRDX2 in colorectal cancer patientsCarcinogenesis20133461265127223393224
   PubMedGoogle Scholar
• AlbertusDLSederCWChenGAZGP1 autoantibody predicts survival and histone deacetylase inhibitors increase expression in lung adenocarcinomaJ Thorac Oncol20083111236124418978557
   PubMedGoogle Scholar
• JungWYSungCOHanSHAZGP-1 immunohistochemical marker in prostate cancer: potential predictive marker of biochemical recurrence in post radical prostatectomy specimensAppl Immunohistochem Mol Morphol201422965265724508823
   PubMedGoogle Scholar
• BundredNJWalkerRAEveringtonDWhiteGKStewartHJMillerWRIs apocrine differentiation in breast carcinoma of prognostic significance?Br J Cancer19906211131172202419
   PubMedGoogle Scholar